|
1
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lam JS, Shvarts O, Leppert JT, Figlin RA
and Belldegrun AS: Renal cell carcinoma 2005: New frontiers in
staging, prognostication and targeted molecular therapy. J Urol.
173:1853–1862. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
4
|
Athar U and Gentile TC: Treatment options
for metastatic renal cell carcinoma: A review. Can J Urol.
15:3954–3966. 2008.PubMed/NCBI
|
|
5
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iyer J, Moghe S, Furukawa M and Tsai MY:
What's Nu(SAP) in mitosis and cancer? Cell Signal. 23:991–998.
2011. View Article : Google Scholar
|
|
7
|
Raemaekers T, Ribbeck K, Beaudouin J,
Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg
J and Carmeliet G: NuSAP, a novel microtubule-associated protein
involved in mitotic spindle organization. J Cell Biol.
162:1017–1029. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vanden Bosch A, Raemaekers T, Denayer S,
Torrekens S, Smets N, Moermans K, Dewerchin M, Carmeliet P and
Carmeliet G: NuSAP is essential for chromatin-induced spindle
formation during early embryogenesis. J Cell Sci. 123:3244–3255.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kokkinakis DM, Liu X and Neuner RD:
Modulation of cell cycle and gene expression in pancreatic tumor
cell lines by methionine deprivation (methionine stress):
Implications to the therapy of pancreatic adenocarcinoma. Mol
Cancer Ther. 4:1338–1348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bogunovic D, O'Neill DW, Belitskaya-Levy
I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R,
Pavlick AC, et al: Immune profile and mitotic index of metastatic
melanoma lesions enhance clinical staging in predicting patient
survival. Proc Natl Acad Sci USA. 106:20429–20434. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marie SK, Okamoto OK, Uno M, Hasegawa AP,
Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr, Toledo
S, et al: Maternal embryonic leucine zipper kinase transcript
abundance correlates with malignancy grade in human astrocytomas.
Int J Cancer. 122:807–815. 2008. View Article : Google Scholar
|
|
12
|
Satow R, Shitashige M, Kanai Y, Takeshita
F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, et
al: Combined functional genome survey of therapeutic targets for
hepatocellular carcinoma. Clin Cancer Res. 16:2518–2528. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gulzar ZG, McKenney JK and Brooks JD:
Increased expression of NuSAP in recurrent prostate cancer is
mediated by E2F1. Oncogene. 32:70–77. 2013. View Article : Google Scholar
|
|
14
|
Chen DT, Nasir A, Culhane A, Venkataramu
C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et
al: Proliferative genes dominate malignancy-risk gene signature in
histologically-normal breast tissue. Breast Cancer Res Treat.
119:335–346. 2010. View Article : Google Scholar
|
|
15
|
Lauss M, Kriegner A, Vierlinger K, Visne
I, Yildiz A, Dilaveroglu E and Noehammer C: Consensus genes of the
literature to predict breast cancer recurrence. Breast Cancer Res
Treat. 110:235–244. 2008. View Article : Google Scholar
|
|
16
|
Cario G, Fetz A, Bretscher C, Möricke A,
Schrauder A, Stanulla M and Schrappe M: Initial leukemic gene
expression profiles of patients with poor in vivo prednisone
response are similar to those of blasts persisting under prednisone
treatment in childhood acute lymphoblastic leukemia. Ann Hematol.
87:709–716. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
18
|
Huang Y, Gao S, Wu S, Song P, Sun X, Hu X,
Zhang S, Yu Y, Zhu J, Li C, et al: Multilayered molecular profiling
supported the monoclonal origin of metastatic renal cell carcinoma.
Int J Cancer. 135:78–87. 2014. View Article : Google Scholar
|
|
19
|
Srinivasan R, Ricketts CJ, Sourbier C and
Linehan WM: New strategies in renal cell carcinoma: Targeting the
genetic and metabolic basis of disease. Clin Cancer Res. 21:10–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jonasch E and Motzer RJ: Ten years of
progress in renal cell carcinoma. J Natl Compr Canc Netw.
10:690–693. 2012.PubMed/NCBI
|
|
21
|
Moarii M, Boeva V, Vert JP and Reyal F:
Changes in correlation between promoter methylation and gene
expression in cancer. BMC Genomics. 16:8732015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Z, Zhuan B, Yan Y, Jiang S and Wang
T: Integrated analyses of copy number variations and gene
differential expression in lung squamous-cell carcinoma. Biol Res.
48:472015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gordon CA, Gulzar ZG and Brooks JD: NUSAP1
expression is upregulated by loss of RB1 in prostate cancer cells.
Prostate. 75:517–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nie J, Wang H, He F and Huang H: Nusap1 is
essential for neural crest cell migration in zebrafish. Protein
Cell. 1:259–266. 2010. View Article : Google Scholar
|
